Rajesh Devraj

2.8k citations

35 papers · 1.9k indexed · 1 hit paper · h-index 20

Organic Chemistry top 2%
- Synthesis and Characterization of Heterocyclic Compounds 7
- Synthesis and biological activity 6
- Quinazolinone synthesis and applications 5
- Synthesis of heterocyclic compounds 4
Computational Theory and Mathematics top 1%
Geriatrics and Gerontology top 5%
Pharmacology top 5%
Physiology top 5%
Molecular Biology
- Melanoma and MAPK Pathways 7
- Chemical Synthesis and Analysis 5
- Cancer therapeutics and mechanisms 4
Spectroscopy
- Analytical Chemistry and Chromatography 3

Co-authors: Aleem Gangjee John J. Parlow Michael S. South Thomas M. Engber Raul Krauss Todd Bosanac Robert Hughes Nigel Greene
Cited by: Organic Chemistry Computational Theory and Mathematics Geriatrics and Gerontology
Journals: Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (6 papers)The Journal of Organic Chemistry (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Rajesh Devraj

35 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Rajesh Devraj

Since Specialization

Citations

This map shows the geographic impact of Rajesh Devraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Devraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Devraj more than expected).

Fields of papers citing papers by Rajesh Devraj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Devraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Devraj. The network helps show where Rajesh Devraj may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rajesh Devraj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rajesh Devraj Line = papers co-authored together Rajesh Devraj links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate Cell Reports ·Robert Hughes,Todd Bosanac,Xianrong Mao,Thomas M. Engber,Aaron DiAntonio,Jeffrey Milbrandt,Rajesh Devraj,Raul Krauss	2021	119
2	cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons Experimental Neurology ·Yo Sasaki,Thomas M. Engber,Robert Hughes,Matthew D. Figley,Aldo Aguayo-Meléndez,Todd Bosanac,Rajesh Devraj,Jeffrey Milbrandt,Raul Krauss,Aaron DiAntonio	2020	73
3	Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration Trends in Pharmacological Sciences ·Raul Krauss,Todd Bosanac,Rajesh Devraj,Thomas M. Engber,Robert Hughes	2020	90
4	Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs Bioorganic & Medicinal Chemistry Letters ·John I. Trujillo,Wei Huang,Robert Hughes,D. Joseph Rogier,Zarina Shameer,Rajesh Devraj,Philip Morton,Chu‐Biao Xue,Motohisa ABE,Maryanne Covington,Robert Newton,Brian Metcalf	2011	4
5	Discovery and Characterization of Atropisomer PH‐797804, a p38 MAP Kinase Inhibitor, as a Clinical Drug Candidate ChemMedChem ·Xing Li,Balekudru Devadas,Rajesh Devraj,Shaun R. Selness,H.-S. Shieh,John K. Walker,Michael K. Mao,Dean Messing,Brian Samas,Jerry Z. Yang,Gary D. Anderson,Elizabeth Webb,Joseph B. Monahan	2011	32
6	Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Balekudru Devadas,Shaun R. Selness,Lei Xing,Ante Ćorluka,马一龙,H.-S. Shieh,Dean Messing,Jerry Z. Yang,Raphael Welter,Gary D. Anderson,Elizabeth Webb,Jian Zhang,Rajesh Devraj,Joseph B. Monahan	2011	19
7	Discovery of 5-substituted-N-arylpyridazinones as inhibitors of p38 MAP kinase Bioorganic & Medicinal Chemistry Letters ·Mi Ru Kim,Michael Hepperle,John K. Walker,Xing Li,Rajesh Devraj,恵次吉川,Y. Cho,Shaun R. Selness	2010	7
8	Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase Bioorganic & Medicinal Chemistry Letters ·John K. Walker,Shaun R. Selness,Rajesh Devraj,Michael Hepperle,Win Naing,H.-S. Shieh,Susanne Minkus,I B Tsorin,Daniel L. Flynn,恵次吉川,Dean Messing,Pilar Del Carmen,Cristiane Faiad,Sajidin Sajidin,Joseph B. Monahan,Joseph P. Portanova	2010	19
9	Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation Journal of Pharmacology and Experimental Therapeutics ·Heidi R. Hope,Gary D. Anderson,Barry Burnette,Robert P. Compton,Rajesh Devraj,Jeffrey L. Hirsch,Robert H. Keith,Boutzoukas A.E.,Gabriel Mbalaviele,Dean Messing,Matthew J. Saabye,John F. Schindler,Shaun R. Selness,Poh Shuah Daniel Yeo,Elizabeth Webb,Jian Zhang,Joseph B. Monahan	2009	46
10	Physiochemical drug properties associated with in vivo toxicological outcomesbreakdown → Bioorganic & Medicinal Chemistry Letters ·Jason D. Hughes,Julian Blagg,David A. Price,Simon Bailey,Gary DeCrescenzo,Rajesh Devraj,Edmund L. Ellsworth,Yvette M. Fobian,厚司設楽,Martine Desenclos,Nigel Greene,Enoch S. Huang,Teresa Krieger-Burke,Jens Loesel,Travis T. Wager,Elías José Bracho Cordero,Yao Zhang	2008	675
11	Solution-phase chemical library synthesis using polymerassisted purification techniques Current Opinion in Chemical Biology ·John J. Parlow,Rajesh Devraj,Michael S. South	1999	75
12	ChemInform Abstract: Highly Efficient Diastereoselective Michael Addition of Various Thiols to (+)‐Brefeldin A. ChemInform ·Tha’er Kanaan,R. D. HAUGWITZ,Rajesh Devraj,John F. Kozlowski,P.E. Fanwick,Mark Cushman	1998	1
13	Comparison of Ternary Complexes ofPneumocystis cariniiand Wild-Type Human Dihydrofolate Reductase with Coenzyme NADPH and a Novel Classical Antitumor Furo[2,3-d]pyrimidine Antifolate Acta Crystallographica Section D Biological Crystallography ·Vivian Cody,Nikolai Galitsky,J.R. Luft,W. Pangborn,Aleem Gangjee,Rajesh Devraj,Sherry F. Queener,Raymond L. Blakley	1997	27
14	Chemical Library Purification Strategies Based on Principles of Complementary Molecular Reactivity and Molecular Recognition Journal of the American Chemical Society ·Daniel L. Flynn,J. Z. CRICH,Rajesh Devraj,Susan L. Hockerman,John J. Parlow,Michael S. South,Scott S. Woodard	1997	169
15	Synthesis of a series of cytotoxic 2-acyl-1,2-dihydroellipticines which inhibit topoisomerase II. PubMed ·Rajesh Devraj,Jurjus Jurayj,赵泽民,З С Миниварова,Mark Cushman	1996	4
16	ChemInform Abstract: Design, Synthesis, and Biological Evaluation of Ellipticine‐Estradiol Conjugates. ChemInform ·Rajesh Devraj,John F. Barrett,Jeffrey Fernandez,John A. Katzenellenbogen,Mark Cushman	1996	1
17	Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines Journal of Medicinal Chemistry ·Aleem Gangjee,Rajesh Devraj,John J. McGuire,Roy L. Kisliuk	1995	56
18	5-Arylthio Substituted 2-Amino-4-oxo-6-methylpyrrolo[2,3-d]pyrimidine Antifolates as Thymidylate Synthase Inhibitors and Antitumor Agents Journal of Medicinal Chemistry ·Aleem Gangjee,Rajesh Devraj,John J. McGuire,Roy L. Kisliuk	1995	34
19	Classical and Nonclassical Furo[2,3-d]pyrimidines as Novel Antifolates: Synthesis and Biological Activities Journal of Medicinal Chemistry ·Aleem Gangjee,Rajesh Devraj,John J. McGuire,Roy L. Kisliuk,Sherry F. Queener,Louis R. Barrows	1994	65
20	Novel 2,4-Diamino-5-Substituted Furo[2,3-d]-Pymmidines as Potential Antifolates Advances in experimental medicine and biology ·Aleem Gangjee,Rajesh Devraj,Sherry F. Queener,Roy L. Kisliuk	1993	1

About Rajesh Devraj

Rajesh Devraj is a scholar working on Organic Chemistry, Physiology and Molecular Biology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (7 papers), Melanoma and MAPK Pathways (7 papers), Synthesis and biological activity (6 papers), Chemical Synthesis and Analysis (5 papers), Quinazolinone synthesis and applications (5 papers), Synthesis of heterocyclic compounds (4 papers), Cancer therapeutics and mechanisms (4 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Organic Chemistry (746 citations), Computational Theory and Mathematics (382 citations) and Geriatrics and Gerontology (83 citations). Rajesh Devraj has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Aleem Gangjee, John J. Parlow, Michael S. South, Thomas M. Engber, Raul Krauss, Todd Bosanac, Robert Hughes, Nigel Greene, Gary DeCrescenzo and Yvette M. Fobian. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, The Journal of Organic Chemistry, Experimental Neurology and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact